Why Does NIPT Miss Triploidy Syndrome in Pregnancy?

Receiving a “normal” or inconclusive screening result when your doctor suspects a serious condition can be incredibly confusing and frightening. Non-Invasive Prenatal Testing (NIPT) is a highly accurate blood test designed to screen for common chromosomal conditions (like Down syndrome). However, many standard NIPTs may not reliably detect triploidy syndrome.

Triploidy is a rare chromosomal condition where a baby has three complete sets of chromosomes (69 in total) instead of the normal two sets (46). It is important to know that triploidy usually results from a random error during fertilization ^[1]. It is not inherited, and it is not caused by anything the parents did or did not do.

Here is a breakdown of why NIPT might miss triploidy, what a “no-call” result means, and how doctors can find a definitive answer.

The Ratio Problem: Why 69 Chromosomes Can Appear “Negative”

Standard NIPTs work by analyzing fragments of cell-free DNA (cfDNA) in the mother’s blood. The test counts these fragments to see if there is an excess amount of specific chromosomes—typically chromosomes 13, 18, and 21. It looks for imbalances by comparing the ratios of these chromosomes against one another ^{[2] [3]}.

Because triploidy involves a complete extra set of all chromosomes, the relative ratio between them remains completely balanced ^[3]. To a standard chromosome-counting NIPT, this balanced ratio may appear negative, meaning the test does not flag an abnormality ^{[2] [4]}. Detection depends heavily on the specific laboratory and the algorithm they use.

Note: Some newer NIPTs use a method called SNP-based testing (Single Nucleotide Polymorphism). These look at DNA sequence differences rather than just counting amounts. While SNP tests can sometimes flag an extra set of chromosomes, they are still screening tests, not diagnostic. An abnormal SNP result can also be caused by a “vanishing twin” (an early twin loss) or maternal genomic factors ^{[2] [5]}.

Placental DNA and “Low Fetal Fraction”

NIPT does not actually test the baby’s DNA directly. Instead, it tests DNA shed by the placenta into the mother’s bloodstream ^{[6] [7]}. The percentage of this placental DNA in the blood sample is called the fetal fraction.

If the fetal fraction is too low, the lab cannot get a reliable reading, and the test will return as a “no call” or “low fetal fraction” result ^[8]. Low fetal fraction is nonspecific and has many common causes, including testing too early in pregnancy, higher maternal body weight, or laboratory factors ^[8]. However, it can also be associated with triploidy:

• Digynic Triploidy: In this subtype, the extra set of chromosomes comes from the mother. Digynic triploidy is often associated with severe, asymmetrical fetal growth restriction and a small, non-molar placenta ^{[9] [10]}. A smaller, underdeveloped placenta may shed less DNA, which can contribute to a low fetal fraction and an inconclusive test result ^{[11] [8]}.
• Diandric Triploidy: In contrast, when the extra set comes from the father (diandric), the placenta is often enlarged or cystic (molar changes) ^[9].

Because low fetal fraction has many causes, it does not diagnose triploidy on its own. A repeat NIPT is sometimes offered, but if ultrasound findings are concerning, waiting for a redraw should not delay diagnostic testing.

Ultrasound Clues and Maternal Symptoms

Because standard cfDNA testing is a screen rather than a diagnosis, normal results do not rule out all abnormalities ^{[12] [13]}. A doctor might suspect triploidy based on other clinical signs:

• Ultrasound findings: Severe growth restriction, multiple physical anomalies, abnormal amniotic fluid levels, or an abnormal placental appearance may warrant further evaluation ^{[3] [13]}.
• Maternal findings: Complications such as early-onset preeclampsia (high blood pressure in pregnancy) or unusual hormone levels can also raise clinical suspicion for triploidy ^[14].

Moving from Screening to Diagnosis

If an ultrasound raises suspicion or an NIPT is persistently inconclusive, you will likely be referred to a maternal-fetal medicine specialist or a genetic counselor ^[12]. They will help you weigh your options through shared decision-making.

To get a definitive answer, doctors must perform invasive diagnostic testing to evaluate the actual cells of the pregnancy. These procedures carry a small risk of procedure-related miscarriage, which your care team will discuss with you.

• Chorionic Villus Sampling (CVS): Usually performed between 10 and 13 weeks, this tests a small sample of tissue from the placenta ^[15]. However, because it tests the placenta, it can be complicated by placental mosaicism (where the placenta’s genetic makeup differs slightly from the fetus) ^{[6] [15]}.
• Amniocentesis: Usually performed after 15 weeks, this tests cells from the amniotic fluid surrounding the baby, providing a more direct look at the baby’s genetic material ^[15].

From these samples, a lab can perform a karyotype (a visual picture of the chromosomes) or other specialized testing, which is much more definitive than NIPT for diagnosing 69 chromosomes ^{[3] [13]}.

Test Comparison Summary

What a Diagnosis Means for You

Hearing that triploidy is suspected or confirmed is devastating. Because the condition involves an entire extra set of chromosomes, it disrupts nearly every aspect of development. Tragically, triploidy is almost universally fatal, typically resulting in miscarriage, stillbirth, or death shortly after birth.

In this incredibly difficult time, you do not have to navigate this alone. Please ask your care team to connect you with a genetic counselor, perinatal social worker, or bereavement support group. They can help you understand your testing options, support your emotional well-being, and guide you through compassionate care planning for your pregnancy.